140 related articles for article (PubMed ID: 3547114)
21. Metabolism of galangin by rat cytochromes P450: relevance to the genotoxicity of galangin.
Silva ID; Rodrigues AS; Gaspar J; Laires A; Rueff J
Mutat Res; 1997 Oct; 393(3):247-57. PubMed ID: 9393617
[TBL] [Abstract][Full Text] [Related]
22. Metabolism and mutagenic activation of 2-acetylaminofluorene by human liver and lung.
Boobis AR; Brodie MJ; McManus ME; Staiano N; Thorgeirsson SS; Davies DS
Adv Exp Med Biol; 1981; 136 Pt B():1193-201. PubMed ID: 7046385
[No Abstract] [Full Text] [Related]
23. Monitoring the exposure of rats to 2-acetylaminofluorene by the estimation of mutagenic activity in excreta, sister-chromatid exchanges in peripheral blood cells and DNA adducts in peripheral blood, liver and spleen.
Willems MI; de Raat WK; Baan RA; Wilmer JW; Lansbergen MJ; Lohman PH
Mutat Res; 1987 Feb; 176(2):211-23. PubMed ID: 3543665
[TBL] [Abstract][Full Text] [Related]
24. Interaction of the synthetic ultimate carcinogens, N-sulfonoxy- and N-acetoxy-2-acetylaminofluorene, and of enzymatically activated N-hydroxy-2-acetylaminofluorene with nucleophiles.
Smith BA; Springfield JR; Gutmann HR
Carcinogenesis; 1986 Mar; 7(3):405-11. PubMed ID: 3512117
[TBL] [Abstract][Full Text] [Related]
25. Differential effect of a microsomal deacetylase inhibition on the mutagenicity in Salmonella typhimurium of 2-acetylaminofluorene by liver homogenates of guinea pigs, mice and rats.
Okuno S; Takeishi K; Seno T
Cancer Lett; 1979 Jan; 6(1):1-5. PubMed ID: 396979
[TBL] [Abstract][Full Text] [Related]
26. The mutagenic potencies of plant extracts containing quercetin in Salmonella typhimurium TA98 and TA100.
Schimmer O; Häfele F; Krüger A
Mutat Res; 1988 Oct; 206(2):201-8. PubMed ID: 3050500
[TBL] [Abstract][Full Text] [Related]
27. The structure-activity relationships of flavonoids as inhibitors of cytochrome P-450 enzymes in rat liver microsomes and the mutagenicity of 2-amino-3-methyl-imidazo[4,5-f]quinoline.
Lee H; Wang HW; Su HY; Hao NJ
Mutagenesis; 1994 Mar; 9(2):101-6. PubMed ID: 8201941
[TBL] [Abstract][Full Text] [Related]
28. Metabolic activation of 2-acetylaminofluorene.
Thorgeirsson SS; Wirth PJ; Staiano N; Smith CL
Adv Exp Med Biol; 1981; 136 Pt B():897-919. PubMed ID: 7046390
[No Abstract] [Full Text] [Related]
29. Inter-individual variation in the mutagenic activation of 2-acetylaminofluorene by human liver in relation to animal metabolic models.
Smith AJ; Chipman JK
Mutagenesis; 1988 Jul; 3(4):323-8. PubMed ID: 3062320
[TBL] [Abstract][Full Text] [Related]
30. Differing activation pathways for 2-acetylaminofluorene to a mutagen in vitro.
McGregor DB; McConville M; Menzies C; Prentice RD
Mutat Res; 1982; 102(1):39-50. PubMed ID: 6750372
[TBL] [Abstract][Full Text] [Related]
31. Influence of disulfiram on mutagenicity of the urinary metabolites of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene in the Salmonella test system.
El-Torkey NM; Weisburger EK
Mutat Res; 1983 Jul; 118(1-2):1-6. PubMed ID: 6346083
[TBL] [Abstract][Full Text] [Related]
32. Flavone mutagenicity in Salmonella typhimurium: dependence on the pKM101 plasmid and excision-repair deficiency.
MacGregor JT; Wilson RE
Environ Mol Mutagen; 1988; 11(3):315-22. PubMed ID: 3281825
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effects of selenium of the mutagenicity of 2-acetylaminofluorene (AAF) and AAF derivatives.
Jacobs MM; Matney TS; Griffin AC
Cancer Lett; 1977 May; 2(6):319-22. PubMed ID: 324608
[TBL] [Abstract][Full Text] [Related]
34. Metabolic formation of pyrenequinones as enhancing agents of mutagenicity in Salmonella.
Okamoto H; Yoshida D
Cancer Lett; 1981 Jan; 11(3):215-20. PubMed ID: 7018664
[TBL] [Abstract][Full Text] [Related]
35. Isolation and studies of the mutagenic activity in the Ames test of flavonoids naturally occurring in medical herbs.
Czeczot H; Tudek B; Kusztelak J; Szymczyk T; Dobrowolska B; Glinkowska G; Malinowski J; Strzelecka H
Mutat Res; 1990 Mar; 240(3):209-16. PubMed ID: 2179716
[TBL] [Abstract][Full Text] [Related]
36. Influence of conjugation reactions on the mutagenicity of aromatic amines.
Hongslo J; Haug LT; Wirth PJ; Møller M; Dybing E; Thorgeirsson SS
Mutat Res; 1983 Feb; 107(2):239-47. PubMed ID: 6346076
[TBL] [Abstract][Full Text] [Related]
37. Comutagenic effect of norharman and harman with 2-acetylaminofluorene derivatives.
Umezawa K; Shirai A; Matsushima T; Sugimura T
Proc Natl Acad Sci U S A; 1978 Feb; 75(2):928-30. PubMed ID: 345280
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of S9 activation by S105 cytosolic fraction.
Forster R; Green MH; Priestley A
Carcinogenesis; 1981; 2(11):1081-5. PubMed ID: 7032740
[TBL] [Abstract][Full Text] [Related]
39. Optimum S9 concentrations in bacterial mutagenicity assays.
Forster R; Green MH; Priestley A
Adv Exp Med Biol; 1981; 136 Pt B():1263-9. PubMed ID: 7046386
[No Abstract] [Full Text] [Related]
40. Involvement of rat cytochrome 1A1 in the biotransformation of kaempferol to quercetin: relevance to the genotoxicity of kaempferol.
Silva ID; Rodrigues AS; Gaspar J; Maia R; Laires A; Rueff J
Mutagenesis; 1997 Sep; 12(5):383-90. PubMed ID: 9379919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
